News


All series


All News

Wavefront-optimized and wavefront-guided laser treatments, which may seem new to many patients, now have 5-year track record and are both significant improvements over conventional laser treatments.

Manage the patient's environment, manage the patient systemically, manage inflammation first, and communicate effectively with patients may be considered the new "rule"book for ocular surface disease management.

Analyses of visual acuity results from phase III clinical trials investigating Q.D. bromfenac sodium ophthalmic solution 0.09% for treatment of inflammation and reduction of pain after cataract surgery show treatment with this nonsteroidal anti-inflammatory drug provides functional benefits in addition to its anti-inflammatory and analgesic effects.

The Hudson Valley Optometric Society, a local affiliate of the New York State Optometric Association and the American Optometric Association, has voted to withhold its 2012 AOA dues, placing them in an escrow account until the AOA withdraws support for the American Board of Opometry and its board certification process, a move the organization says it hopes that other societies will follow.

A post hoc analysis of data collected in two published, pivotal clinical trials demonstrates that in addition to its efficacy for treating inflammation following ocular surgery, loteprednol etabonate ophthalmic suspension 0.5% provides statistically significant relief of postoperative pain and other symptoms.

Many optometrists recommend or prescribe fish oil supplements to their patients with dry eye, but not many realize that there have never been any randomized, controlled trials conducted to establish that fatty acids such as the omega 3s found in fish oil work to relieve symptoms of dry eye.

A three-dimensional simultaneous stereoscopic retinal camera that allows stereo images to be taken in one shot, offers an automatic mosaic merge function, and provides a full 45-degree field angle in two-dimensional mode has been introduced by Kowa Optimed Inc.